Cardiometabolic risk

There are 75 papers on cardiometabolic risk in aging research: 19 trials and 37 observational studies in people, 18 reviews. The newest story, Nov 21, 2026: “Fatty liver disease linked to earlier colorectal cancer risk”.

Disease

75 papers study it2,067 more mention it4 findings

364 new papers in 30 daysSee all 2,142 papers on cardiometabolic risk

“GDF-15 rose progressively across groups (control 337.7 ± 82.6, low-risk 865.8 ± 76.9, high-risk 1130.7 ± 79.2 pg/mL; p < 0.001).”
Growth differentiation factor-15 and body roundness index in relation to cardiometabolic risk in young adults with obesityEndocrine2026doi:10.1007/s12020-026-04784-4
  • Human trial19
  • Humans37

Associations

3

GDF-15

upin humans1

1 study
  1. GDF-15 predicts cardiometabolic risk in humans (low-risk versus high-risk groups) (AUC 0.677, 95% CI 0.535-0.819).

    Humanslow-risk versus high-risk groupsn = 90

  2. GDF-15 is associated with cardiometabolic risk in humans (comparison of control, low-risk and high-risk groups) (control 337.7 ± 82.6, low-risk 865.8 ± 76.9, high-risk 1130.7 ± 79.2 pg/mL).

    Humanscomparison of control, low-risk and high-risk groupsn = 90

More on GDF-15

Leptin

upin humans1

1 study
  1. Leptin is associated with cardiometabolic risk in humans (comparison of risk groups with controls).

    Humanscomparison of risk groups with controlsn = 90

More on Leptin

Breastfeeding

downin humans1

1 study
  1. Breastfeeding lowers the risk of cardiometabolic risk in humans.

    Reviewfemales

More on Breastfeeding

Trial sponsors

Funding

60 grants since 2016

National Heart, Lung, and Blood Institute$23.4MNational Institute on Aging$5.1MNational Institute of Diabetes and Digestive and Kidney Diseases$9.6M

Latest

Research Square

Fatty liver disease linked to earlier colorectal cancer risk

People with three fatty liver disease subtypes were estimated to reach the same colorectal cancer risk 2–6 years earlier than people without fatty liver disease.People with three fatty liver disease subtypes were estimated to reach the same colorectal cancer risk 2–6 years earlier than people without fatty liver disease.

Preprint: cohort · 191,837 peopleColorectal cancer

See all 2,142 papers on cardiometabolic risk